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We describe a synthetic sialic acid analogue, 9-thioacetamldo-N-acetylneurammic acid (9-thioacetamldo-Neu5Ac). which is recognized by the 
receptor-binding activity of influenza C virus, but is resistant o the receptor-destroying enzyme (acetylesterase) of this virus. Following transfer 
of the analogue to the surface of receptor-negative c lls, influenza C virus 1s able to attach to these cells. but is unable to infect the cells. This result 
suggests that mactivatlon of virus receptors by the receptor-destroying enzyme 1s essential for initiation of infection Because of their unique 
properties such analogues promise to be powerful chemotherapeutic agents. 
Influenza C virus; N-Acetyl-9-0-acetylneuraminic acid, Slalic acid analogue: Receptor determinant 
1. INTRODUCTION 
Influenza C virus usually infects the upper respiratory 
tract of man and causes a mild disease characterized by 
fever and long-lasting nasal discharge [l], but lower 
respiratory infections have also been reported [2]. On a 
molecular level, influenza C virus is characterized by 
having only one surface glycoprotein (HEF). which is 
responsible for three biological activities: receptor-bind- 
ing, receptor-inactivation, and fusion activity (reviewed 
in [3]). Virus attachment to the cell surface is accom- 
plished by the ability of HEF to recognize receptors the 
crucial determinant of which is N-acetyl-9-O-acetylneu- 
raminic acid (Neu5,9Ac,) (Fig. 1) [4,5]. The receptor- 
destroying activity of influenza C virus has been identi- 
fied as an acetylesterase [6]. The enzyme inactivates the 
cellular receptors for this virus by releasing the 9-0- 
acetyl group of sialic acid. The viral esterase may be 
important for several stages of the virus infection. Some 
data suggest that the enzyme is required for a step fol- 
lowing attachment to the surface receptors [7]. It has 
also been speculated that the acetylesterase may be re- 
quired for virus maturation or for inactivating compet- 
itive inhibitors, which are present in the mucus covering 
the respiratory tract [3]. 
Recently, we have shown that a synthetic sialic acid 
analogue, 9-acetamido-N-acetylneuraminic acid (Fig. 1) 
181, can be used by influenza C virus as a receptor deter- 
minant for attachment to the cell surface [9]. Erythro- 
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cytes containing the analogue were agglutinated to the 
same titer as cells containing N-acetyl-9-O-acetylneu- 
raminic acid, the natural receptor determinant. How- 
ever, the sialic acid analogue is not a substrate for the 
receptor-destroying enzyme: the amide linkage at C-9 of 
sialic acid is resistant to the action of the acetylesterase 
[9]. Because of these characteristics, the analogue or 
variants of it can be used to analyze the importance of 
the receptor-destroying enzyme for the infection of cul- 
tured cells. 
2. EXPERIMENTAL 
Strain Johannesburg/l/66 of influenza C virus was grown in embry- 
onated chicken eggs as described previously [6]. 
MDCK II cells were grown as described previously [5] For virus 
infection, confluent monolayers in 35 mm plastic petri dishes were 
incubated with 0.2 ml of stock virus diluted with PBS to obtain an 
m o.i. of about 10 TCID,&ell. After an adsorption time of 1 h at room 
temperature. cells were washed with PBS and incubated with mmlmal 
essential medium at 33°C. Two days post-infection the yield of virus 
released mto the supernatant was determined by HA titration [IO] 
2.3. Synthesis oj siulic ucrd unulogurs 
9-Thioacetamldo-9-deowy-N-acetylneuraminic acid was obtained 
by thioacetylation of 9-amino-9-deoxy-N-acetylneurdmmic acid The 
detailed synthesis will be described elsewhere (manuscript in prepara- 
tion) ConversIon to the CMP-activated compound was accomplished 
as described previously [8]. 
2.4 Rrsialyhtron of cells 
Erythrocytes from one-day-old chicken and MDCK II cells were 
treated with neuramimdase and resialylated as described previously 
[lO.l I]. 
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Fig. 1. Structures of 9-O-acetyl-N-acetylneuraminic acid (1) 9-acet- 
amido-N-acetylneuraminic acid (2) and 9-thtoacetamido-N-ace- 
tylneuramimc acid (3) R, following sugar in the oligosaccharide chain. 
3. RESULTS AND DISCUSSION 
As we have shown recently, replacement of the 9-0- 
acetyl group of sialic acid by an acetamide group does 
not abolish the ability of the molecule to serve as a 
receptor determinant for influenza C virus [9]. We ana- 
lyzed whether the receptor-binding activity of the virus 
also recognizes a sialic acid molecule containing a thio- 
acetamido group at position 9. The analogue 9-thioacet- 
Table I 
Ability of influenza C virus to agglutinate erythrocytes containing 
either the natural receptor determinant, Neu5,9Ac,. or a sialic acid 
analogue (9-thioacetamido-N-acetylneurammic acid or 9-acetamido- 
N-acetylneuraminic acid, respectively) on the surface 
CMP- HA activity (HA U/ml) 
sialic 
acid (nmole) 
Neu5,9Ac, 9-thioacetamido- 9-acetamido- 
Neu5Ac NeuSAc 
0.25 <2 c2 <2 
0.5 256 <2 <2 
1.0 256 32 <2 
2.0 256 64 64 
4.0 256 256 256 
Siahc acids were transferred to the surface of neuraminidase-treated 
erythrocytes from one-day-old chicken by incubation with 2.5 mU 
Gal/Jl,4GlcNAc cc2,6-sialyltransferase and the amount of CMP-actt- 
vated siahc acid indicated above. Resialylated cells were used to deter- 
mine the HA titer of allantoic fluid containing influenza C virus. 
amido-9-deoxy-N-acetylneuraminic acid (9-thioacet- 
amido-Neu5Ac) (Fig. 1) was transferred to the surface 
of erythrocytes which were resistant to agglutination by 
influenza C virus. Following resialylation, erythrocytes 
containing the analogue were agglutinated by influenza 
C virus as efficiently as cells which had been sialylated 
to contain 9-0-acetylated sialic acid (Table I). The 
amount of CMP-9-thioacetamido-NeuSAc required for 
positive results was higher compared to Neu5,9Ac,, but 
somewhat lower than in the case of 9-acetamido- 
NeuSAc. This result indicates that influenza C virus can 
use the 9-thioacetamido compound as a receptor deter- 
minant for attachment to cells. 
In order to analyze whether the analogue can serve 
as a receptor determinant also on cultured cells, 9-thio- 
acetamido-Neu5Ac acid was attached to the surface of 
MDCK II cells. These cells are resistant to infection by 
influenza C virus due to a lack of receptors. After gen- 
eration of receptors by incorporation of exogenous gan- 
gliosides or by enzymatic transfer of 9-0-acetylated 
sialic acid, the cells become susceptible to infection 
[5,12]. As shown in Table II, low virus yields were ob- 
tained already when 2 nmol of CMP-9-O-acetyl-N-ace- 
tylneuraminic acid were used for the resialylation of 
MDCK II cells. After infection of cells that had been 
sialylated in the presence of 10 nmol of CMP- 
Neu5,9Ac,, a titer of 256 HA U/ml was determined in 
the supernatant which is comparable to the amount of 
virus released by permissive MDCK I cells. On the 
other hand, influenza C virus was unable to infect cells 
containing the thioacetamido analogue, even if 50 nmol 
were used during the sialylation reaction. This result 
indicates that the analogue cannot serve as a receptor 
determinant for the initiation of infection. From the re- 
sult with erythrocytes (Table I), it is expected that influ- 
enza C virus is able to attach to MDCK II cells contain- 
ing the analogue. In fact, binding of virus to cell surface 
proteins resialylated to contain 9-thioacetamido-NeuAc 
can be demonstrated by overlay assays (manuscript in 
preparation). Therefore, it is not the attachment but a 
subsequent step of the infectious cycle which prevents 
influenza C virus from using the analogue as a receptor 
determinant for infection of cells. As the analogue is 
resistant to inactivation by the viral acetylesterase, it is 
likely that the receptor-destroying enzyme of this virus 
plays an important role at the post-adsorption stage of 
the infection. This conclusion was also drawn from 
studies with esterase inhibitors [7]. The inactivation of 
the virus receptors is not an absolute requirement for 
the fusion activity of influenza C virus, because erythro- 
cytes containing 9-acetamido-NeuSAc are efficiently he- 
molyzed though this receptor determinant cannot be 
inactivated by the viral acetylesterase [9]. Studies with 
esterase inhibitors suggested that the enzyme is required 
for the fusion activity only, if low amounts of virus are 
used for the hemolysis assay [ 131. A possible role for the 
receptor-destroying enzyme in the initiation of infection 
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Table II 
Ability of influenza C virus to infect MDCK II cells modified to 
contam either the natural receptor determinant, Neu5,9AcZ. or a siahc 
acid analogue. 9-thioacetamido-N-acetylneurammic acid. on the 
surface 
CMP-dahc acid 
(nmole) 
HA activity (HA U/ml) 
Neu5,9Ac, 9-thioacetamido-NeuSAc 
2 16 <2 
10 256 <2 
50 256 <2 
Sialic acids were transferred to the surface of neuramimdase-treated 
MDCK II cells by incubation with 1 mU Galbl.4GlcNAc a2,6-sia- 
lyltransferase and the amount of CMP-activated sialic acid indicated 
above. Resialylated cells were Infected with influenza C virus and two 
days post-infection the yield of virus released mto the supernatant uas 
determmed by HA titration 
might be to facilitate the transfer from primary attach- 
ment sites to secondary attachment sites. For example, 
a transfer from glycoproteins to glycolipids would result 
in a closer contact between the viral and the cellular 
membrane which may be favorable for the subsequent 
fusion event. Secondary attachment sites might also be 
cellular glycoproteins of coated pits. which are endocy- 
tosed and therefore suitable for directing the bound 
virus particle to the acidic compartment which is re- 
quired to trigger the fusion between influenza viruses 
and cellular membranes. 
Whatever the role of the receptor-destroying enzyme 
may be, the results obtained demonstrate that synthetic 
sialic acid analogues can effectively interfere with initia- 
tion of infection by viruses which contain a receptor- 
destroying enzyme. Preliminary studies have shown that 
polymers containing 9-thioacetamido-NeuSAc inhibit 
virus infection. Because of their inhibitory activity the 
analogues promise to be powerful chemotherapeutic 
agents, which should be applicable also to other viruses 
with receptor-destroying enzymes. 
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